ABT Abbott Laboratories
Stock · NYSE · United States · Healthcare · US0028241000
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by Abbott Laboratories, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price
107.25 USD
-1.87%
52-week range
81.97 – 132.03
Dividend yield2.35%
Market cap185.8B
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 12 Nov 2026 21:23. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
28 Jan 2027
in 76 days · 08:00 · estimate 1.64
Last results
1.42 vs 1.42 estimated
21 Oct 2026 · In line +0.0%
Beat the estimate
4 of 12
0 missed · 8 in line
Average surprise
+1.0%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 28 Jan 2027 08:00 | 1.64 | — | — | Upcoming |
| 21 Oct 2026 07:00 | 1.42 | 1.42 | +0.0% | In line |
| 16 Jul 2026 07:00 | 1.28 | 1.31 | +2.6% | Beat |
| 16 Apr 2026 07:00 | 1.15 | 1.15 | +0.3% | In line |
| 22 Jan 2026 07:00 | 1.49 | 1.50 | +0.3% | In line |
| 15 Oct 2025 07:00 | 1.30 | 1.30 | +0.1% | In line |
| 17 Jul 2025 07:00 | 1.26 | 1.26 | +0.3% | In line |
| 16 Apr 2025 07:00 | 1.07 | 1.09 | +1.7% | Beat |
| 22 Jan 2025 07:00 | 1.34 | 1.34 | -0.2% | In line |
| 16 Oct 2024 07:00 | 1.20 | 1.21 | +0.8% | In line |
| 18 Jul 2024 07:00 | 1.10 | 1.14 | +3.2% | Beat |
| 17 Apr 2024 07:00 | 0.95 | 0.98 | +2.8% | Beat |
| 24 Jan 2024 07:00 | 1.19 | 1.19 | +0.0% | In line |
| 18 Oct 2023 07:00 | 1.10 | 1.14 | +3.7% | Beat |
| 20 Jul 2023 07:00 | 1.05 | 1.08 | +2.9% | Beat |
| 19 Apr 2023 07:00 | 0.99 | 1.03 | +4.3% | Beat |
| 25 Jan 2023 07:00 | 0.94 | 1.03 | +9.7% | Beat |
| 19 Oct 2022 07:00 | 0.94 | 1.15 | +22.9% | Beat |
| 20 Jul 2022 07:00 | 1.14 | 1.43 | +25.3% | Beat |
| 20 Apr 2022 07:00 | 1.46 | 1.73 | +18.1% | Beat |
| 26 Jan 2022 07:00 | 1.21 | 1.32 | +9.5% | Beat |
| 20 Oct 2021 07:00 | 0.95 | 1.40 | +47.9% | Beat |
| 22 Jul 2021 07:00 | 1.02 | 1.17 | +14.9% | Beat |
| 20 Apr 2021 07:00 | 1.27 | 1.32 | +4.0% | Beat |
| 27 Jan 2021 07:00 | 1.35 | 1.45 | +7.1% | Beat |
| 21 Oct 2020 07:00 | 0.91 | 0.98 | +8.0% | Beat |
| 16 Jul 2020 07:00 | 0.42 | 0.57 | +36.9% | Beat |
| 16 Apr 2020 08:00 | 0.61 | 0.65 | +7.3% | Beat |
| 22 Jan 2020 07:00 | 0.95 | 0.95 | +0.4% | In line |
| 16 Oct 2019 07:00 | 0.84 | 0.84 | -0.2% | In line |
| 17 Jul 2019 07:00 | 0.80 | 0.82 | +2.2% | Beat |
| 17 Apr 2019 07:00 | 0.62 | 0.63 | +2.1% | Beat |
| 23 Jan 2019 07:00 | 0.81 | 0.81 | +0.2% | In line |
| 17 Oct 2018 07:00 | 0.75 | 0.75 | +0.6% | In line |
| 18 Jul 2018 07:00 | 0.71 | 0.73 | +2.9% | Beat |
| 18 Apr 2018 07:00 | 0.58 | 0.59 | +1.9% | Beat |
| 24 Jan 2018 07:00 | 0.73 | 0.74 | +1.2% | Beat |
| 18 Oct 2017 07:00 | 0.65 | 0.66 | +1.1% | Beat |
| 20 Jul 2017 07:00 | 0.61 | 0.62 | +2.5% | Beat |
| 19 Apr 2017 07:00 | 0.43 | 0.48 | +11.5% | Beat |
| 25 Jan 2017 07:00 | 0.65 | 0.65 | +0.6% | In line |
| 19 Oct 2016 07:00 | 0.58 | 0.59 | +1.4% | Beat |
| 20 Jul 2016 07:00 | 0.53 | 0.55 | +3.2% | Beat |
| 20 Apr 2016 07:00 | 0.39 | 0.41 | +4.5% | Beat |
| 28 Jan 2016 07:00 | 0.61 | 0.62 | +1.7% | Beat |
| 21 Oct 2015 07:00 | 0.53 | 0.54 | +1.2% | Beat |
| 22 Jul 2015 07:00 | 0.50 | 0.52 | +3.5% | Beat |
| 22 Apr 2015 07:00 | 0.42 | 0.47 | +12.7% | Beat |
| 29 Jan 2015 07:00 | 0.63 | 0.62 | -1.8% | Miss |
| 22 Oct 2014 07:00 | 0.60 | 0.62 | +3.7% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 44.3B | +5.7% | 6.5B | 14.7% | 3.72 | -51.3% | 7.4B |
| 2024 | 42B | +4.6% | 13.4B | 31.9% | 7.64 | +134.4% | 6.4B |
| 2023 | 40.1B | -8.1% | 5.7B | 14.3% | 3.26 | -16.6% | 5.1B |
| 2022 | 43.7B | — | 6.9B | 15.9% | 3.91 | — | 7.8B |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 12 Nov 2026 | 110.32 | 110.78 | 106.89 | 107.25 | -1.87% | 8,206,047 | |
| 11 Nov 2026 | 109.88 | 110.33 | 108.95 | 109.29 | -1.06% | 8,970,200 | |
| 10 Nov 2026 | 109.82 | 110.84 | 108.72 | 110.46 | -0.05% | 7,377,800 | |
| 09 Nov 2026 | 110.88 | 111.01 | 108.93 | 110.51 | +0.53% | 7,838,000 | |
| 06 Nov 2026 | 111.08 | 111.81 | 109.81 | 109.93 | -3.23% | 8,345,100 | |
| 05 Nov 2026 | 117.00 | 117.07 | 112.66 | 113.60 | -1.65% | 10,282,500 | |
| 04 Nov 2026 | 112.65 | 116.22 | 112.12 | 115.51 | +5.59% | 12,711,300 | |
| 03 Nov 2026 | 109.36 | 110.62 | 108.94 | 109.40 | -0.69% | 7,302,700 | |
| 02 Nov 2026 | 106.89 | 110.48 | 106.40 | 110.16 | +3.73% | 8,846,400 | |
| 30 Oct 2026 | 106.15 | 106.85 | 104.60 | 106.20 | +1.56% | 8,439,700 | |
| 1,254 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Microfluidic Device Systems - Global Strategic Business Report 2026: Capitalize on 8.7% CAGR to $11.1 Billion by 2032 | Abbott, Danaher, Bio-Rad, and Siemens Healthineers Shape the Competition (opens in a new tab) 12 Nov 2026 14:57
- Is Abbott Laboratories (ABT) Undervalued On New Device And Test Launches? (opens in a new tab) Simply Wall St. · 12 Nov 2026 14:10
- Abbott vs. Medtronic: Which Dividend Stock Pays You More in 10 Years? (opens in a new tab) TIKR · 12 Nov 2026 12:56
- Warren Buffett Says His Favorite Holding Period Is Forever. A Secretary Who Paid $180 for 3 Shares in 1935 and Never Sold Died Worth $7 Million. Here’s What Her Rule Does for $600,000 in One Stock Today (opens in a new tab) 24/7 Wall St. · 12 Nov 2026 03:23
- Is Trending Stock Abbott Laboratories (ABT) a Buy Now? (opens in a new tab) Zacks · 11 Nov 2026 20:21
- Can UltiSynq Lead Boost Abbott's Cardiac Rhythm Management Business? (opens in a new tab) Zacks · 11 Nov 2026 15:47
- Molecular Cytogenetics - Global Strategic Business Report: Capitalize on 8.8% CAGR to US$3.5 Billion by 2030; Outmaneuver Abbott, Agilent, Bio-Rad, Illumina and Roche Amid Tariff Shifts (opens in a new tab) 11 Nov 2026 14:13
- Gene Amplification Technologies - Global Strategic Business Report: Capture $4.4B in New Revenue by 2030 as Abbott, Bio-Rad, bioMerieux, Cepheid and Becton Dickinson Battle for Share (opens in a new tab) 10 Nov 2026 14:20
- New Abbott Panbio™ COVID-19/Flu A&B Self-Test Helps Canadian Families Make Informed Decisions During Respiratory Illness Season (opens in a new tab) 10 Nov 2026 11:08
- What Are Wall Street Analysts' Target Price for Abbott Stock? (opens in a new tab) Barchart · 10 Nov 2026 08:59
- Does FDA Device Approval Change The Bull Case For Abbott (ABT)? (opens in a new tab) Simply Wall St. · 07 Nov 2026 20:12
- Global Biohacking Wearable and Consumer Longevity Device Market Report 2026 | Capitalize on AI Biometrics as Apple, Samsung, Abbott, and Oura Drive Market to $45.03 Billion by 2030 (opens in a new tab) 06 Nov 2026 14:14
- Bioelectronic Medicine and Neural Interface Devices Global Market Report 2026 | Capture 20.9% CAGR as Abbott, Boston Scientific, Neuralink and Science Advance Closed-Loop Systems (opens in a new tab) 05 Nov 2026 15:39
- Are You Overpaying For Abbott Stock Versus Its Rivals? (opens in a new tab) Trefis · 05 Nov 2026 12:32
- Cell Counting - Global Strategic Business Report 2026: Capitalize on US$6 Billion Growth by 2032 as Abbott, Becton Dickinson, Bio-Rad, Danaher, and Sysmex Drive Automation (opens in a new tab) 04 Nov 2026 15:16
Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 109.29 USD
- Market cap
- 185.8B
- Dividend yield
- 2.35%
- 5-year average yield
- 1.86%
- Payout ratio
- 93%
- Last dividend
- 0.6300 USD · 15 Oct 2026
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Medical Devices
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 15 Oct 2026 | 0.6300 USD |
| 15 Jul 2026 | 0.6300 USD |
| 15 Apr 2026 | 0.6300 USD |
| 15 Jan 2026 | 0.6300 USD |
| 8 older dividends: create a free account to see them | |
Why this score
Similar shares
Follow ABT and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.